Bioxytran Launches Joint Venture with the Heme Foundation for Development of Universal Oxygen Carrier
$BIXT - a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19, other viral diseases, and stroke - is pleased to announce a Joint Venture (the “JV”) with the Heme Foundation (“Heme” or the “Foundation”) to develop a Universal Oxygen Carrier (“UOC”) as an alternative to blood transfusions.
July 17, 2024